The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Discussions on raising age for free subway rides gain momentum

  • 3

    2-year work experience prerequisite lifted for foreign shipyard welders

  • 5

    US reaffirms nuclear security assurances to South Korea

  • 7

    Families of Itaewon victims on collision course with Seoul City

  • 9

    William Franklin Sands' diplomatic and undiplomatic views of late Joseon

  • 11

    Will KT, POSCO replace CEOs as Shinhan, Woori did?

  • 13

    Korea as sublime, strange, and familiar

  • 15

    TXT, Le Sserafim top Oricon album and singles chart

  • 17

    Chinese spy balloon 'transits' Latin America after first craft flies over US

  • 19

    Blinken scraps rare China trip over alleged spy balloon

  • 2

    INTERVIEWTati Gabrielle, actress of Korean, African-American descent, feels proud of her heritage

  • 4

    Families of Itaewon crowd stampede victims clash with police over installation of memorial altar

  • 6

    China expresses 'strong dissatisfaction' over US shooting down balloon

  • 8

    Opposition party takes to streets to protest prosecution probes into leader

  • 10

    Korean American Rep. Young Kim named chair of House Indo-Pacific subcommittee

  • 12

    US remains committed to using full range of capabilities to defend S. Korea: Blinken

  • 14

    US shoots down suspected Chinese spy balloon with a single missile

  • 16

    Wang Yi urges US to 'avoid misjudgment' over balloon controversy

  • 18

    President Yoon at odds with politician who helped him win election

  • 20

    Musk didn't defraud investors with 2018 Tesla tweets

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Mon, February 6, 2023 | 21:48
Korean biotech firms show off capabilities in Europe
Korean biotech firms show off capabilities in Europe
HLB, Celltrion, NeoImmuneTech and other Korean biotech companies confirmed their competitiveness in Europe as they showcased their new drug development capabilities at the European Society for Medical Oncology (ESMO) Congress, an annual medical oncology fair to share the latest developments in cancer research, they said Tuesday. This year's ESMO Congress was held in Paris for...
Baek Byung-yeul | 2022-09-13 16:46
HLB's liver cancer treatment shows longest overall survival
HLB's liver cancer treatment shows longest overall survival
Local biotech company HLB said its liver cancer treatment candidate Rivoceranib showed over 22 months of overall survival in its Phase 3 clinical trials, the longest in any liver cancer treatment, the company said, Thursday. The company said it plans to hold a meeting with the U.S. Food and Drug Administration (FDA) to apply for approval for new drugs, given the effectiveness...
Baek Byung-yeul | 2022-09-08 14:20
Celltrion receives approval to sell anticancer biosimilar Vegzelma in Europe
Celltrion receives approval to sell anticancer biosimilar Vegzelma in Europe
Korean biopharmaceutical firm Celltrion said Friday it has received an approval to sell its anticancer biosimilar Vegzelma in Europe.
2022-08-19 15:52
Samsung Biologics, C&T invest in US biotech firm Senda Biosciences
Samsung Biologics, C&T invest in US biotech firm Senda Biosciences
An investment fund created by Samsung Biologics and Samsung C&T invested $15 million into U.S.-based biotechnology company Senda Biosciences as part of their efforts to foster core technology required to develop next-generation biopharmaceuticals, Samsung Biologics said on Wednesday. Samsung Biologics said the Life Science Fund, jointly formed by itself and Samsung C&T, decid...
Baek Byung-yeul | 2022-08-17 16:16
Yoon promises to foster bio-health industry
Yoon promises to foster bio-health industry
President Yoon Suk-yeol vowed Wednesday to foster the bio-health industry into a key national strategic industry as he met with health experts at a medical research facility.
2022-07-27 14:13
Daesang to set up joint venture with China Sinopharm International
Daesang to set up joint venture with China Sinopharm International
Daesang Life Science, a Korean manufacturer of health functional foods, said Wednesday it has inked a letter of intent with China Sinopharm International to set up a joint venture in a bid to make forays into the Chinese market.
2022-07-27 14:13
Matica Bio aims to join global top 5 cell & gene therapy producers by 2030
Matica Bio aims to join global top 5 cell & gene therapy producers by 2030
Matica Biotechnology, a U.S. subsidiary of CHA Biotech, revealed its goal to join the global top five manufacturers of cell and gene therapy and generate sales of over 1 trillion won ($762.8 million) by 2030, its CEO said Thursday. “The global cell and gene therapy's CDMO (contract development and manufacturing organization) market is expected to grow by more than 20 percent ...
Baek Byung-yeul | 2022-07-21 16:10
Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development
Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development
Korea's state-run National Institute of Infectious Diseases (NIID) said Wednesday it has reached an agreement with Moderna, a U.S. biotech company, to cooperate in the development of a messenger RNA (mRNA) vaccine candidate for severe fever and thrombocytopenia syndrome (SFTS).
2022-07-20 13:18
Split from GSK, Haleon seeks to solidify consumer healthcare leadership
Split from GSK, Haleon seeks to solidify consumer healthcare leadership
Consumer healthcare company Haleon was officially launched on Monday (U.K. time) after completing its spinoff from GSK, its Korean unit said Tuesday. Haleon is a global leading company in the consumer healthcare markets of 170 countries, selling numerous well-known brands such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, Parodontax and Centrum.
Baek Byung-yeul | 2022-07-19 16:34
Moderna says committed to making Omicron-adaptive vaccine candidate available in Aug.
Moderna says committed to making Omicron-adaptive vaccine candidate available in Aug.
Moderna, a U.S. biotech company specializing in messenger RNA (mRNA) coronavirus vaccines, is committed to making its new bivalent vaccine candidate available next month, which reportedly demonstrates a superior antibody response against Omicron variants.
2022-07-19 15:29
12 3 4567
Top 10 Stories
12-year work experience prerequisite lifted for foreign shipyard welders 2-year work experience prerequisite lifted for foreign shipyard welders
2Families of Itaewon victims on collision course with Seoul City Families of Itaewon victims on collision course with Seoul City
3President Yoon at odds with politician who helped him win election President Yoon at odds with politician who helped him win election
49 fishermen, including 2 Vietnamese, missing in boat incident 9 fishermen, including 2 Vietnamese, missing in boat incident
5LG publishes Korea's first group-level net zero report LG publishes Korea's first group-level net zero report
6Conflict reignites over relocation of POSCO Holdings to Pohang Conflict reignites over relocation of POSCO Holdings to Pohang
7[VIDEO] Filipina K-pop idol and K-drama actress react to stereotypes about the Philippines VIDEOFilipina K-pop idol and K-drama actress react to stereotypes about the Philippines
8FSC approves security token transactions in Korea FSC approves security token transactions in Korea
9Hyundai Motor's technology helps team become WTCR double champion Hyundai Motor's technology helps team become WTCR double champion
10Tasks lie ahead for Woori's next chairman nominee picked amid controversy Tasks lie ahead for Woori's next chairman nominee picked amid controversy
DARKROOM
  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

  • World Cup 2022 France vs Morocco

    World Cup 2022 France vs Morocco

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group